• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of the tumor suppressor gene WT1 in human leukemogenesis.

Research Project

Project/Area Number 11470210
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionOsaka University

Principal Investigator

SUGIYAMA Haruo  Osaka University Medical School, Professor, 医学部, 教授 (70162906)

Co-Investigator(Kenkyū-buntansha) SOMA Toshihiro  Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助手 (40273619)
OKA Yoshihiro  Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助手 (20273691)
OGAWA Hiroyasu  Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助教授 (80194447)
OJI Yusuke  Osaka University Medical School, Associate Professor, 医学部, 助手 (20294100)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥14,500,000 (Direct Cost: ¥14,500,000)
Fiscal Year 2000: ¥5,300,000 (Direct Cost: ¥5,300,000)
Fiscal Year 1999: ¥9,200,000 (Direct Cost: ¥9,200,000)
Keywordsleukemia / The WT1 gene / apoptosis / WT1 / tumor suppressor gene / oncogene / WWドメイン
Research Abstract

1. The wild-type WT1 gene was expressed in not only leukemia but also solid tumors, including lung cancers. The growth of these cancer cells was inhibited by the treatment with WT1 antisense oligomers.
2. Leukemic cell line K562 was arrested at G_2/M checkpoint by the treatment with WT1 antisense oligomers.
3. We have established the method to measure individually four different splicing variants (17AA+/KTS+, 17AA+/KTS-, 17AA-/KTS+, 17AA-/KTS-). By using this method, it was found that a 17AA+/KTS+ transcript was major in leukemic cells.
4. When the wild-type WT1 gene was transfected into myeloid progenitor cell 32D and the gene was constitutively expressed, the apoptosis of the 32D cells was inhibited.
5. A novel WT1-binding protein was cloned and named as WTIP was localized in splicesome and so considered as a splicing factor.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Tsuboi,A. et al.: "The Wilms' tumor gene : its oncogenic function and clinical application."Int.J.Hemaol,. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Harada,Y. et al.: "The WT1 expression in human testicular germ cell tumors."Mol.Urol. 3. 357-363 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tamaki,H. et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes."Leukemia.. 13. 393-399 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsuboi,A. et al.: "Constitutive expression of the Wilms'tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)."Leuk.Res.. 23. 499-505 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sako,M. et al.: "Abnormal expression of the Wilms' tumor gene WT1 in juvenile chronic myeloid leukemia and infantile monosomy 7 syndrome."Leuk.Res.. 22. 965-967 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Oji,Y. et al.: "Cytotoxic T lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination."Jpn.J.Cancer Res.. 90. 194-204 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsuboi, A.et al.: "The Wilms' tumor gene : its oncogenic function and clinical application."Int.J.Hemaol. (in press.).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Harada, Y.et al.: "The WT1 expression in human testicular germ cell tumors."Mol.Urol. 3. 357-363 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tamaki, H.et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes."Leukemia. 13. 393-399 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsuboi, A.et al.: "Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)."Leuk.Res. 23. 499-505 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sako, M.et al.: "Abnormal expression of the Wilms' tumor gene WT1 in juvenile chronic myeloid leukemia and infantile monosomy 7 syndrome."Leuk.Res. 22. 965-967 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Oji, Y.et al.: "Cytotoxic T lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination."Jpn.J.Cancer Res. 90. 194-204 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sugiyama,H. et al.: "The Wilms' tumor gene : its oncogenic function and clinical application."Int.J.Hemaol,. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] Harada,Y. et al.: "The WT1 expression in human testicular germ cell tumors."Mol.Urol.. 3. 357-363 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tamaki,H. et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes."Leukemia.. 13. 393-399 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsuboi,A. et al.: "Constitutive exptession of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenito cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)."Leuk.Res.. 23. 499-505 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sako,M. et al.: "Abnormal expression of the Wilms' tumor gene WT1 in juvenile chronic myeloid leukemia and infantile monosomy 7 syndrome."Leuk.Res.. 22. 965-967 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Oji,Y. et al.: "Expression of the Wilms' tumor gene WT1 solid tumors and its essential role in tumor cell growth."Jpn.J.Cancer Res.. 90. 194-204 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsuboi A.et al.: "Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes then proliferation in response to granulocyte-colony stimulating factor(G-CSF)"Leukemia Research. 23. 499-505 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Oji Y.et al.: "Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth"Japanese Journal of Cancer Research. 90. 194-204 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yamagami T.et al.: "Suppression of Wilms' tumor gone (WT1) expression induces G_2/M arrest in leukemic cells"Leukemia Research. 30. 55-61 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Inoue K.et al.: "Wilms' tumor gone (WT1)competes with differentiation-inducing signal in hematopoietic progenitor cells"Blood. 91. 2969-2976 (1998)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi